Abstract:Background: The research aimed to evaluate the efficacy and safety of different radiation doses (45Gy and 50.4Gy) on neoadjuvant in patients with LARC.Methods: Patients with LARC between January 2016 and June 2021 were retrospectively enrolled in the study, all of them underwent neoadjuvant chemoradiotherapy and radical surgical. XELOX regimen was administered for two cycles before nCRT. 72 patients received radiation dose with 50.4Gy while 45 patients with 45Gy. During radiotherapy, concurrent chemotherapy wa… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.